fbpx
Medical Innovation Exchange

Centessa dumps top program after evidence of tolerability issues stunt market potential

https://www.fiercebiotech.com/biotech/centessa-dumps-most-developed-program-after-evidence-tolerability-issues-stunted-market

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.